35.41
price down icon1.44%   -0.575
 
loading
Precedente Chiudi:
$35.99
Aprire:
$36.23
Volume 24 ore:
802.24K
Relative Volume:
0.39
Capitalizzazione di mercato:
$5.62B
Reddito:
$264.79M
Utile/perdita netta:
$-14.36M
Rapporto P/E:
-321.95
EPS:
-0.11
Flusso di cassa netto:
$-28.11M
1 W Prestazione:
-5.08%
1M Prestazione:
-3.40%
6M Prestazione:
+6.29%
1 anno Prestazione:
+79.05%
Intervallo 1D:
Value
$35.39
$36.50
Intervallo di 1 settimana:
Value
$35.52
$37.93
Portata 52W:
Value
$16.65
$46.48

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name
Nome
Tg Therapeutics Inc
Name
Telefono
(212) 554-4484
Name
Indirizzo
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Name
Dipendente
352
Name
Cinguettio
@TGTherapeutics
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
TGTX's Discussions on Twitter

Confronta TGTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TGTX
Tg Therapeutics Inc
35.42 5.86B 264.79M -14.36M -28.11M -0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.00 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.58 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.20 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
597.70 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
306.34 31.54B 3.81B -644.79M -669.77M -6.24

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-10 Ripresa Goldman Neutral
2024-10-29 Iniziato TD Cowen Buy
2023-08-02 Aggiornamento Goldman Sell → Neutral
2023-06-26 Ripresa Jefferies Buy
2022-05-20 Iniziato BofA Securities Underperform
2022-02-23 Reiterato B. Riley Securities Buy
2021-11-15 Downgrade Goldman Neutral → Sell
2021-04-20 Iniziato Goldman Neutral
2021-04-19 Reiterato H.C. Wainwright Buy
2020-09-01 Iniziato JP Morgan Overweight
2020-08-11 Reiterato H.C. Wainwright Buy
2020-06-05 Iniziato Evercore ISI Outperform
2020-01-17 Reiterato H.C. Wainwright Buy
2019-11-27 Ripresa B. Riley FBR Buy
2019-02-06 Ripresa Jefferies Buy
2018-09-25 Downgrade Raymond James Strong Buy → Outperform
2018-03-09 Reiterato B. Riley FBR, Inc. Buy
2017-12-01 Ripresa B. Riley FBR, Inc. Buy
2017-11-14 Ripresa H.C. Wainwright Buy
2017-04-25 Iniziato Jefferies Buy
2017-03-06 Reiterato FBR & Co. Outperform
2016-10-06 Ripresa Brean Capital Buy
2016-05-27 Iniziato SunTrust Buy
2015-12-01 Iniziato FBR Capital Outperform
2015-09-09 Iniziato Raymond James Strong Buy
2015-08-12 Ripresa H.C. Wainwright Buy
2015-06-19 Reiterato Brean Capital Buy
2014-12-11 Reiterato ROTH Capital Buy
2014-12-10 Reiterato ROTH Capital Buy
Mostra tutto

Tg Therapeutics Inc Borsa (TGTX) Ultime notizie

pulisher
10:00 AM

TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q2 Release - Yahoo Finance

10:00 AM
pulisher
Jul 28, 2025

What are analysts’ price targets for TG Therapeutics Inc. in the next 12 monthsBest Dividend Updates From AI Tools - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying TG Therapeutics Inc. stockCapitalize on proven trading setups - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How strong is TG Therapeutics Inc. company’s balance sheetAccelerate your capital gains today - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does TG Therapeutics Inc. compare to its industry peersDiscover high-growth stocks for your portfolio - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive TG Therapeutics Inc. stock higher in 2025Exceptional portfolio growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Does TG Therapeutics Inc. stock perform well during market downturnsUnlock expert insights for smarter investing - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Jim Cramer on TG Therapeutics: “You Should Buy the Stock” - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

Will TG Therapeutics Inc. stock benefit from interest rate changesSkyrocketing profit margins - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), TG Therapeutics (TGTX) and Ardelyx (ARDX) - The Globe and Mail

Jul 24, 2025
pulisher
Jul 23, 2025

TG Therapeutics Inc. Stock Analysis and ForecastTremendous growth potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and TG Therapeutics (TGTX) - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

Is TG Therapeutics Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about TG Therapeutics Inc. stockRapid wealth multiplication - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives TG Therapeutics Inc. stock priceUnstoppable trading performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 18, 2025

How To Trade (TGTX) - news.stocktradersdaily.com

Jul 18, 2025
pulisher
Jul 11, 2025

TG Therapeutics Joins Rank Of Stocks With RS Ratings Over 90 - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

A Note On TG Therapeutics, Inc.'s (NASDAQ:TGTX) ROE and Debt To Equity - simplywall.st

Jul 11, 2025
pulisher
Jul 10, 2025

Goldman Sachs resumes TG Therapeutics stock coverage with Neutral rating By Investing.com - Investing.com Canada

Jul 10, 2025
pulisher
Jul 10, 2025

We Think TG Therapeutics (NASDAQ:TGTX) Can Stay On Top Of Its Debt - 富途牛牛

Jul 10, 2025
pulisher
Jul 03, 2025

Cramer's Lightning Round: TG Therapeutics is a buy - MSN

Jul 03, 2025
pulisher
Jul 02, 2025

SHAREHOLDER COMPLAINT: Levi & Korsinsky LLP Files Case in U.S. District Court to Recover Losses Suffered By Investors in TG Therapeutics, Inc.Sets Lead Plaintiff Deadline of March 7, 2017 - ACCESS Newswire

Jul 02, 2025
pulisher
Jul 02, 2025

14 Stocks Jim Cramer Recently Looked At - Insider Monkey

Jul 02, 2025
pulisher
Jul 01, 2025

Cramer Backs This Mining Giant After $1.6B Bet - Benzinga

Jul 01, 2025
pulisher
Jun 30, 2025

TG Therapeutics: Cramer's Bullish Call Amid Clinical Pipeline Potential - AInvest

Jun 30, 2025
pulisher
Jun 28, 2025

TG Therapeutics: Strong Execution Tempered By An Evolving Market (NASDAQ:TGTX) - Seeking Alpha

Jun 28, 2025
pulisher
Jun 27, 2025

Long Term Trading Analysis for (TGTX) - news.stocktradersdaily.com

Jun 27, 2025
pulisher
Jun 25, 2025

TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel (NASDAQ:TGTX) - Seeking Alpha

Jun 25, 2025
pulisher
Jun 23, 2025

Exploring 3 High Growth Tech Stocks In The US Market - Yahoo Finance

Jun 23, 2025
pulisher
Jun 19, 2025

Have Insiders Sold TG Therapeutics Shares Recently? - simplywall.st

Jun 19, 2025
pulisher
Jun 17, 2025

Insider Selling: Yann Echelard Unloads $369K Of TG Therapeutics Stock - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Tg therapeutics director Yann Echelard sells $369,400 in stock - Investing.com Australia

Jun 17, 2025
pulisher
Jun 17, 2025

(TGTX) Trading Advice - news.stocktradersdaily.com

Jun 17, 2025

Tg Therapeutics Inc Azioni (TGTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$76.55
price up icon 9.07%
$37.48
price up icon 1.12%
$104.20
price up icon 2.31%
$26.92
price down icon 2.09%
$111.44
price down icon 1.18%
biotechnology ONC
$306.30
price up icon 3.90%
Capitalizzazione:     |  Volume (24 ore):